Send this to a friend

CT joins $13.5M multistate settlement with Boehringer Ingelheim

Connecticut is joining 49 other states and the District of Columbia in a $13.5 million settlement with Ridgefield's Boehringer Ingelheim Pharmaceuticals Inc. to resolve allegations it engaged in off-label marketing and was misleading in its promotion of four prescription drugs.
The settlement requires court approval before it’s final, according to today's announcement from Attorney General George Jepsen and state Department of Consumer Protec ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media